Substitution of a hydrogen atom with its heavy isotope deuterium entails the addition of one
neutron to a molecule. Despite being a subtle change, this structural modification, known as …

Tardive dyskinesia (TD), a movement disorder associated with antipsychotics, most
frequently affects the lower face and jaw muscles, but can also affect walking, breathing and …

Purpose Tardive dyskinesia (TD) is a hyperkinetic movement disorder in which patients
experience abnormal involuntary movements that can have profound negative impacts on …

Dystonia is a complex disorder with numerous presentations occurring in isolation or in
combination with other neurologic symptoms. Its treatment has been significantly improved …

The term, tardive dyskinesia (TD), originally was coined by Faurbye and colleagues 1 in
their description of delayed-onset, persistent, rhythmic, stereotyped movements after …

Vesicular monoamine transporters (VMATs) are key regulators of neurotransmitter release
responsible for controlling numerous physiological, cognitive, emotional, and behavioral …

Movement disorders of the mouth encompass a spectrum of hyperactive movements
involving the muscles of the orofacial complex. They are rare conditions and are described …

Tardive dyskinesia (TD) is a hyperkinetic movement disorder caused by the use of
dopamine receptor-blocking agents (DRBAs), a category of medications that includes first …

Aim Valbenazine is approved in the US for treatment of tardive dyskinesia (TD); however,
efficacy/safety data in Asian populations are lacking. We assessed the efficacy/safety of …

Tardive syndrome (TS) is an iatrogenic, often persistent movement disorder caused by drugs
that block dopamine receptors. It has a broad phenotype including movement …